Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jeanette Stålcrantz"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Maternal vaccination against pertussis is safe and provides effective protection against pertussis for the newborn, but the vaccine coverage rate remains generally low. Norway is currently planning for introduction of routine maternal pertussis vacci
Externí odkaz:
https://doaj.org/article/91e6c28e667847cab9ab5fa3a6d673a0
Autor:
Jeanette Stålcrantz, Anja Bråthen Kristoffersen, Håkon Bøås, Lamprini Veneti, Elina Seppälä, Nina Aasand, Olav Hungnes, Reidar Kvåle, Karoline Bragstad, Eirik Alnes Buanes, Robert Whittaker
Publikováno v:
Scandinavian journal of public health. 50(6)
Using individual-level national registry data, we conducted a cohort study to estimate differences in the length of hospital stay, and risk of admission to an intensive care unit and in-hospital death among patients infected with the severe acute res
Autor:
Lamprini Veneti, Håkon Bøås, Anja Bråthen Kristoffersen, Jeanette Stålcrantz, Karoline Bragstad, Olav Hungnes, Margrethe Larsdatter Storm, Nina Aasand, Gunnar Rø, Jostein Starrfelt, Elina Seppälä, Reidar Kvåle, Line Vold, Karin Nygård, Eirik Alnes Buanes, Robert Whittaker
Publikováno v:
pii=2200077
Eurosurveillance
Eurosurveillance
We included 39,524 COVID-19 Omicron and 51,481 Delta cases reported in Norway from December 2021 to January 2022. We estimated a 73% reduced risk of hospitalisation (adjusted hazard ratio: 0.27; 95% confidence interval: 0.20–0.36) for Omicron compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7ba45f7fe9c4c0938aca3a65ee93777
https://hdl.handle.net/11250/2993447
https://hdl.handle.net/11250/2993447
Autor:
Ole Herman Ambur, Berit Feiring, Mona Hansen, Lill Trogstad, Irene Kraus Christiansen, Jeanette Stålcrantz, Per Magnus, Christine M. Jonassen, Ida Laake
Publikováno v:
Journal of Infectious Diseases
The Journal of Infectious Diseases
The Journal of Infectious Diseases
High HPV vaccine uptake in a single-cohort program aimed at largely HPV-naive girls reduced vaccine types by 90% in vaccinated and 54% in unvaccinated girls. Indication of cross-protection in both vaccinated and unvaccinated girls was also observed.<
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc8429000dfc48d89ffed240e8b8a3f0
https://hdl.handle.net/10642/6086
https://hdl.handle.net/10642/6086
Autor:
Per Magnus, Inger Cappelen, Lill Trogstad, Jeanette Stålcrantz, Berit Feiring, Tor Molden, Siri E. Håberg, Ida Laake, Bjørn Heine Strand, Ólöf Anna Steingrímsdóttir
Publikováno v:
BMJ Open
Objective Vaccine against human papillomavirus (HPV) has been offered free of charge to all 12-year-old girls in Norway since 2009. Nevertheless, the uptake of HPV vaccine is lower than for other childhood vaccines. The aim of this study was to exami